logo

For the Inventor, By the Inventor

John S Lollar

Decatur, GA, United States of America

John S Lollar

LinkedIn

This inventor holds 24 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Factor VIII Research. Top assignees: Emory University, Expression Therapeutics, LLC, Ipsen Biopharm Limited. Active years: 1994-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John S Lollar. Retrieved from https://idiyas.com/inventor/john-s-lollar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 70.8



Average Co-Inventor Count = 1.3

ph-index = 12

Forward Citations = 566(Granted Patents)


Company Filing History:

goldMedal20 out of 1,024 
 
Emory University
 patents
silverMedal3 out of 4 
 
Expression Therapeutics, LLC
 patents
bronzeMedal2 out of 46 
 
Ipsen Biopharm Limited
 patents
4. 1 out of 1,201 
 
Baxter Healthcare Sa
 patents
5. 1 out of 2,533 
 
Baxter International Inc.
 patents
6. 1 out of 2,373 
 
Regents of the University of Minnesota
 patents
where one patent can have more than one assignee

Years Active: 1994-2015

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Factor VIII
Modified Factor VIII
Porcine B-domainless fVIII
High-level Expressor
Transgenic Circulating Endothelial Cells
Hybrid Human/Animal
Glycosylated Factor VIII
Amino Acid Sequences
24 patents (USPTO):Explore Patents
1. 8951515 - Modified factor VIII (2015-02-10),
2. 8519111 - Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use (2013-08-27),
3. 8501694 - Method of administering porcine B-domainless fVIII (2013-08-06),
4. 8188246 - Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use (2012-05-29),
5. 8101718 - Methods of administering porcine B-domainless fVIII (2012-01-24),
6. 7635763 - Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use (2009-12-22),
7. 7576181 - Method of administering porcine B-domainless fVIII (2009-08-18),
8. 7560107 - Modified factor VIII (2009-07-14),
9. 7122634 - Modified factor VIII (2006-10-17),
10. 7033791 - Nucleic acid molecules encoding modified factor VIII proteins, expression products, and methods of making the same (2006-04-25),
11. 7012132 - Modified factor VIII (2006-03-14),
12. 6852537 - Transgenic circulating endothelial cells (2005-02-08),
13. 6770744 - Modified factor VIII (2004-08-03),
14. 6759216 - Glycosylated, low antigenicity low immunogenicity factor VIII (2004-07-06),
15. 6517830 - Compositions and methods for the expression of factor VIII polypeptides and uses therefor (2003-02-11),

Title: The Innovative Journey of John S Lollar

Introduction:

John S Lollar, a distinguished inventor hailing from Decatur, Georgia, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents:

John S Lollar's latest patents include cutting-edge technologies in the realm of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights:

With a career spanning over two decades, John S Lollar has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of what is possible. His innovative spirit has led to the creation of numerous patented inventions that have revolutionized industries.

Collaborations:

Throughout his career, John S Lollar has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion:

In conclusion, John S Lollar's passion for innovation, coupled with his dedication to creating impactful solutions, has solidified his position as a trailblazing inventor in the world of technology. His relentless pursuit of excellence continues to inspire future generations of inventors to think outside the box and push the boundaries of what is possible in the ever-evolving landscape of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…